PortalPublikationenPerioperative goal-directed therapy - What is the evidence?

Perioperative goal-directed therapy - What is the evidence?

Standard

Perioperative goal-directed therapy - What is the evidence? / Kaufmann, Thomas; Saugel, Bernd; Scheeren, Thomas W L.

in: BEST PRAC RES-CL ANA, Jahrgang 33, Nr. 2, 06.2019, S. 179-187.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Kaufmann, T, Saugel, B & Scheeren, TWL 2019, 'Perioperative goal-directed therapy - What is the evidence?', BEST PRAC RES-CL ANA, Jg. 33, Nr. 2, S. 179-187. https://doi.org/10.1016/j.bpa.2019.05.005

APA

Kaufmann, T., Saugel, B., & Scheeren, T. W. L. (2019). Perioperative goal-directed therapy - What is the evidence? BEST PRAC RES-CL ANA, 33(2), 179-187. https://doi.org/10.1016/j.bpa.2019.05.005

Vancouver

Kaufmann T, Saugel B, Scheeren TWL. Perioperative goal-directed therapy - What is the evidence? BEST PRAC RES-CL ANA. 2019 Jun;33(2):179-187. https://doi.org/10.1016/j.bpa.2019.05.005

Bibtex

@article{91eb137c7a5f47ee9f5734d0e2d29579,
title = "Perioperative goal-directed therapy - What is the evidence?",
abstract = "Perioperative goal-directed therapy aims at optimizing global hemodynamics during the perioperative period by titrating fluids, vasopressors, and/or inotropes to predefined hemodynamic goals. There is evidence on the benefit of perioperative goal-directed therapy, but its adoption into clinical practice is slow and incomprehensive. Current evidence indicates that treating patients according to perioperative goal-directed therapy protocols reduces morbidity and mortality, particularly in patients having high-risk surgery. Perioperative goal-directed therapy protocols need to be started early, should include vasoactive agents in addition to fluids, and should target blood flow related variables. Future promising developments in the field of perioperative goal-directed therapy include personalized hemodynamic management and closed-loop system management.",
author = "Thomas Kaufmann and Bernd Saugel and Scheeren, {Thomas W L}",
note = "Copyright {\textcopyright} 2019 Elsevier Ltd. All rights reserved.",
year = "2019",
month = jun,
doi = "10.1016/j.bpa.2019.05.005",
language = "English",
volume = "33",
pages = "179--187",
journal = "BEST PRAC RES-CL ANA",
issn = "1521-6896",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - Perioperative goal-directed therapy - What is the evidence?

AU - Kaufmann, Thomas

AU - Saugel, Bernd

AU - Scheeren, Thomas W L

N1 - Copyright © 2019 Elsevier Ltd. All rights reserved.

PY - 2019/6

Y1 - 2019/6

N2 - Perioperative goal-directed therapy aims at optimizing global hemodynamics during the perioperative period by titrating fluids, vasopressors, and/or inotropes to predefined hemodynamic goals. There is evidence on the benefit of perioperative goal-directed therapy, but its adoption into clinical practice is slow and incomprehensive. Current evidence indicates that treating patients according to perioperative goal-directed therapy protocols reduces morbidity and mortality, particularly in patients having high-risk surgery. Perioperative goal-directed therapy protocols need to be started early, should include vasoactive agents in addition to fluids, and should target blood flow related variables. Future promising developments in the field of perioperative goal-directed therapy include personalized hemodynamic management and closed-loop system management.

AB - Perioperative goal-directed therapy aims at optimizing global hemodynamics during the perioperative period by titrating fluids, vasopressors, and/or inotropes to predefined hemodynamic goals. There is evidence on the benefit of perioperative goal-directed therapy, but its adoption into clinical practice is slow and incomprehensive. Current evidence indicates that treating patients according to perioperative goal-directed therapy protocols reduces morbidity and mortality, particularly in patients having high-risk surgery. Perioperative goal-directed therapy protocols need to be started early, should include vasoactive agents in addition to fluids, and should target blood flow related variables. Future promising developments in the field of perioperative goal-directed therapy include personalized hemodynamic management and closed-loop system management.

U2 - 10.1016/j.bpa.2019.05.005

DO - 10.1016/j.bpa.2019.05.005

M3 - SCORING: Review article

C2 - 31582097

VL - 33

SP - 179

EP - 187

JO - BEST PRAC RES-CL ANA

JF - BEST PRAC RES-CL ANA

SN - 1521-6896

IS - 2

ER -